Biocryst Pharmaceuticals (BCRX) Notes Payables (2014 - 2021)
Biocryst Pharmaceuticals' (BCRX) quarterly Notes Payables came in at $30.0 million in Q3 2021, little changed YoY from $29.9 million in Q3 2020, and little changed on a QoQ basis from $30.0 million in Q2 2021.
Biocryst Pharmaceuticals (BCRX) Notes Payables (2014 - 2021) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 8 years of Notes Payables data on file, last reported at $30.0 million in Q3 2021.
- Quarterly Notes Payables changed 0.37% year-over-year to $30.0 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $30.0 million (changed 0.37% YoY) and the FY2020 annual result came in at $30.0 million, up 1.49% from the prior year.
- Notes Payables steadied at $30.0 million in Q3 2021, from $30.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $30.0 million in Q4 2020 to a low of $28.4 million in Q1 2017.
- A 5-year average of $29.3 million and a median of $29.3 million in 2019 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2017 — Notes Payables grew 1.57% — and 2021, when it rose 0.37%.
- Tracing BCRX's Notes Payables over 5 years: stood at $28.7 million in 2017, then climbed by 1.53% to $29.1 million in 2018, then increased by 1.51% to $29.6 million in 2019, then increased by 1.49% to $30.0 million in 2020, then changed by 0.0% to $30.0 million in 2021.
- The last three Notes Payables figures came in at $30.0 million (Q3 2021), $30.0 million (Q2 2021), and $30.0 million (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 30.00 Mn |
| Jun 30, 2021 | 30.00 Mn |
| Mar 31, 2021 | 30.00 Mn |
| Dec 31, 2020 | 30.00 Mn |
| Sep 30, 2020 | 29.89 Mn |
| Mar 31, 2020 | 29.67 Mn |
| Dec 31, 2019 | 29.56 Mn |
| Sep 30, 2019 | 29.45 Mn |
| Jun 30, 2019 | 29.34 Mn |
| Mar 31, 2019 | 29.23 Mn |
| Dec 31, 2018 | 29.12 Mn |
| Sep 30, 2018 | 29.01 Mn |
| Jun 30, 2018 | 28.90 Mn |
| Mar 31, 2018 | 28.79 Mn |
| Dec 31, 2017 | 28.68 Mn |
| Sep 30, 2017 | 28.57 Mn |
| Jun 30, 2017 | 28.46 Mn |
| Mar 31, 2017 | 28.35 Mn |
| Dec 31, 2016 | 28.24 Mn |
| Sep 30, 2016 | 28.13 Mn |